Tomás Navarro-Rodríguez

Author

Also Known As

NAVARRO-RODRIGUEZ, Tomás, RODRIGUES, Tomas Navarro, T Navarro-Rodriguez, T Navarro-Rodríguez, T Rodriguez, T. N. Rodriguez, T. NAVARRO‐RODRIGUEZ, T. Navarro-Rodriguez, T. Navarro‐Rodriguez, T. Rodríguez

158

Publications

2.2K

Citations

H-Index

Concepts

All Affiliations

Universidade de São Paulo Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo Southern Arizona VA Health Care System University of Arizona Harvard University

About

Tomás Navarro-Rodríguez is an author at Universidade de São Paulo specializing in medicine, gastroenterology, and anesthesiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	14	541
2	Health Sciences	2	2	27
3	Emergency Medicine	2	2	46
4	Anesthesia	1	1	52
5	Clinical Nutrition	1	1	13

Tomás Navarro-Rodríguez

Publications

1.9K

Citations

H-Index

Page 1

	Year	Citations
Effect of Genotype-Guided Warfarin Dosing on Clinical Events and Anticoagulation Control Among Patients Undergoing Hip or Knee Arthroplasty Brian F. Gage, Anne R. Bass, Hannah Lin, JAMA	2017	233
Lugol's Dye Spray Chromoendoscopy Establishes Early Diagnosis of Esophageal Cancer in Patients with Primary Head and Neck Cancer Cláudio L. Hashimoto, Kiyoshi Iriya, Elisa Ryoka Baba, The American Journal of Gastroenterology	2005	149
Upper GI tract findings in patients with heartburn in whom proton pump inhibitor treatment failed versus those not receiving antireflux treatment Choo Hean Poh, Anita Gąsiorowska, Tomás Navarro-Rodríguez, Gastrointestinal Endoscopy UrologyGastroenterologyPump Inhibitor TreatmentClinical GastroenterologySurgery	2009	146
Guidelines for the diagnosis and management of gastroesophageal reflux disease: an evidence-based consensus Joaquim P. Moraes-Filho, Tomás Navarro-Rodríguez, Ricardo C. Barbuti, Arquivos de Gastroenterologia	2010	89
Association of a probiotic to a Helicobacter pylorieradication regimen does not increase efficacy or decreases the adverse effects of the treatment: a prospective, randomized, double-blind, placebo-controlled study Tomás Navarro-Rodríguez, Fernando Marcuz Silva, Ricardo C. Barbuti, BMC Gastroenterology	2013	82
Esophageal involvement and interstitial lung disease in mixed connective tissue disease M.N. Fagundes, M. T. C. Caleiro, Tomás Navarro-Rodríguez, Respiratory Medicine EsophagusAdvanced Lung DiseaseRespiratory DiseasesImmunologyPathology	2009	80
Comparison of the Degree of Duodenogastroesophageal Reflux and Acid Reflux Between Patients Who Failed to Respond and Those Who Were Successfully Treated With a Proton Pump Inhibitor Once Daily Anita Gąsiorowska, Tomás Navarro-Rodríguez, Christopher S. Wendel, The American Journal of Gastroenterology	2009	63
Prolonged measurement improves the assessment of the barrier function of the esophago‐gastric junction by high‐resolution manometry Dorothea Jasper, Natália Sousa Freitas Queiroz, Michael Hollenstein, Neurogastroenterology & Motility	2016	59
Helicobacter pylori antibiotic resistance in Brazil: clarithromycin is still a good option Jaime Natan Eisig, Fernando Marcuz Silva, Ricardo C. Barbuti, Arquivos de Gastroenterologia	2011	56
No Correlation of <i>bab</i>A2 with <i>vac</i>A and <i>cag</i>A Genotypes of <i>Helicobacter pylori</i> and Grading of Gastritis from Peptic Ulcer Disease Patients in Brazil Rejane Mattar, Aníbal Ferreira dos Santos, Jaime Natan Eisig, Helicobacter	2005	55

Page 1